Rescimetol

This classification denotes an antihypertensive agent with the molecular formula C33H38N2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 25YF317R6S, chemically known as yohimban-16-carboxylic acid, 18-((3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propenyl)oxy)-11,17-dimethoxy-, methyl ester, (3-beta,16-beta,17-alpha,18-beta,20-alpha)- but generally known as rescimetol, which bears US NIH Compound Identifier 5282209. European Medicines Agency schedules Rescimetol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10284MIG. The term RESCIMETOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). RESCIMETOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rescimetol under HS 29399900 and SITC 54149. As of Q4 2014, RESCIMETOL remains the US FDA Preferred Term for this commodity. Rescimetol bears US NLM identifiers UMLS ID C2347955 and NCI Concept Code C72977. SMILES: O(C1C(C2C(CN3C(C2)c2[nH]c4c(c2CC3)ccc(OC)c4)CC1OC(=O)/C=C/c1cc(OC)c(O)cc1)C(=O)OC)C.